Atlas Trials

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

Clinical trial NCT05352321 · RECRUITING

Trial details

NCT number
NCT05352321
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2022-06-01
Primary completion
2025-06-01
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.